↓ Skip to main content

New Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness

Overview of attention for article published in Frontiers in oncology, September 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
1 news outlet
twitter
4 X users

Citations

dimensions_citation
104 Dimensions

Readers on

mendeley
179 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
New Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness
Published in
Frontiers in oncology, September 2019
DOI 10.3389/fonc.2019.00953
Pubmed ID
Authors

Haitang Yang, Shun-Qing Liang, Ralph A. Schmid, Ren-Wang Peng

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 179 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 179 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 35 20%
Student > Master 23 13%
Researcher 22 12%
Student > Bachelor 17 9%
Other 8 4%
Other 15 8%
Unknown 59 33%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 53 30%
Medicine and Dentistry 24 13%
Agricultural and Biological Sciences 10 6%
Pharmacology, Toxicology and Pharmaceutical Science 9 5%
Chemistry 4 2%
Other 17 9%
Unknown 62 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 April 2020.
All research outputs
#3,206,810
of 25,932,719 outputs
Outputs from Frontiers in oncology
#857
of 22,839 outputs
Outputs of similar age
#62,556
of 359,795 outputs
Outputs of similar age from Frontiers in oncology
#25
of 426 outputs
Altmetric has tracked 25,932,719 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,839 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 359,795 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 426 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.